Report overview
Rising pet adoption coupled with rising concerns regarding pet health and prevalence of bacterial infection, especially in dogs, is anticipated to further propel the market growth. Leptospirosis, staphylococcal infection, bacterial ear infection, actinomycosis, and nocardiosis are some of the most common forms of infections in pets. Moreover, pets are susceptible to bacterial diseases, such as plague, brucellosis, and Lyme disease. According to the qualitative report by the CDC in 2018, cats are more prone to plague than dogs and can pass on the infection to humans as well.
This report aims to provide a comprehensive presentation of the global market for Pets Anti-infective Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pets Anti-infective Drugs. This report contains market size and forecasts of Pets Anti-infective Drugs in global, including the following market information:
Global Pets Anti-infective Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Pets Anti-infective Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Injection Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pets Anti-infective Drugs include Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol and Bimeda Animal Health, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pets Anti-infective Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pets Anti-infective Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Pets Anti-infective Drugs Market Segment Percentages, by Type, 2022 (%)
Injection
Oral
Others
Global Pets Anti-infective Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Pets Anti-infective Drugs Market Segment Percentages, by Application, 2022 (%)
Dog
Cat
Others
Global Pets Anti-infective Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Pets Anti-infective Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pets Anti-infective Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pets Anti-infective Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim
Zoetis
Merck
Elanco
Bayer
Virbac
Ceva Sante Animale
Vetoquinol
Bimeda Animal Health
Chanelle
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pets Anti-infective Drugs, market overview.
Chapter 2: Global Pets Anti-infective Drugs market size in revenue.
Chapter 3: Detailed analysis of Pets Anti-infective Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pets Anti-infective Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
